Antimicrobial therapy in experimental pseudomonas infection
Thomas, M.Z.; Southern, P.M.
Texas Reports on Biology and Medicine 32(2): 569-577
1974
ISSN/ISBN: 0040-4675 PMID: 4372741 Document Number: 76761
Document emailed within 1 workday
Related Documents
Postel, J.; Allgöwer, M.; Burkhart, F.; Müller, W.; Städtler, K.; Schoenenberger, G.A. 1974: Pathogenetic and immunotherapeutic significance of a cutaneous burn toxin in experimental pseudomonas infection Helvetica Chirurgica Acta 41(1-2): 7-11Litovchenko, P.P. 1980: Effect of chlorhexidine bigluconate on the development of experimental Pseudomonas aeruginosa eye infection in rabbits Mikrobiolohichnyi Zhurnal 42(1): 103-108
Meitert, E.; Petrovici, M.; Sima, F.; Costache, G.; Savulian, C. 1987: Investigation on the therapeutical efficiency of some adapted bacteriophages in experimental infection with Pseudomonas aeruginosa Archives Roumaines de Pathologie Experimentales et de Microbiologie 46(1): 17-26
Mai, K.; Eckhardt, R. 1972: Treatment of experimental Pseudomonas aeruginosa infection with carbenicillin and antiserum. Dose-effect relations Arzneimittel-Forschung 22(4): 809-813
Shcherbakova, E.G.; Medvedeva, M.M.; Rastunova, G.A.; Sobolev, V.R. 1975: Action of gentamicin, tobramycin and their combinations with prodigiozan in an experimental infection caused by Pseudomonas aeruginosa Antibiotiki 20(12): 1112-1115
Okada, K.; Kawaharajo, K.; Kasai, T.; Homma, J.Y. 1980: Effects of somatic component of Pseudomonas aeruginosa on protective immunity in experimental mouse burn infection Japanese Journal of Experimental Medicine 50(1): 53-61
Clinch, T.E.; Hobden, J.A.; Hill, J.M.; O'Callaghan, R.J.; Engel, L.S.; Kaufmann, H.E. 1992: Collagen shields containing tobramycin for sustained therapy (24 hours) of experimental Pseudomonas keratitis Clao Journal: Official Publication of the Contact Lens Association of Ophthalmologists Inc 18(4): 245-247
Salageanu, A.; Ceacareanu, B.; Popescu, D.; Istrate, N.; Szegli, G. 1998: Experimental studies on bacterial product CANTASTIM derived from Pseudomonas aeruginosa. II. Protective effect in Salmonella typhimurium infection Roumanian Archives of Microbiology and Immunology 56(1-2): 17-26
Faliŝevac, J. 1976: Changes in the ecology of infection and various problems of antimicrobial therapy and prevention Vojnosanitetski Pregled 33(6): 413-418
Svirskaia, L.M. 1988: Routes of the transmission of Pseudomonas aeruginosa infection in resuscitation and intensive therapy departments Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1988(6): 32-34
Samsygin, S.A.; Ovchinnikova, E.A.; Krasovskaia, T.V.; Dolgina, E.N.; Ekk, N.D. 1992: The efficacy of specific plasma in the therapy of newborn infants with a Pseudomonas aeruginosa surgical infection Khirurgiia 1992(11-12): 61-65
Gamero Delgado, M.C.; García-Mayorgas, A.D.; Rodríguez, F.; Ibarra, A.; Casal, M. 2007: Susceptibility and resistence of Pseudomonas aeruginosa to antimicrobial agents Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 20(2): 230-233
Igari, J.; Oguri, T.; Kosakai, N. 1986: In vitro susceptibility of Pseudomonas maltophilia to antimicrobial agents Japanese Journal of Antibiotics 39(1): 121-126
Aswapokee, N.; Pruksachatvuthi, S.; Susaengrat, W. 1990: In vitro activities of antimicrobial combination against Pseudomonas pseudomallei Journal of the Medical Association of Thailand 73(2): 59-63
Shigeta, S.; Goto, S.; Ishida, N. 1971: Pseudomonas aeruginosa infection in the hospital environment. 2. Pigment production and serotype of Pseudomonas aeruginosa isolated from clinical specimens Rinsho Byori. Japanese Journal of Clinical Pathology 19(1): 77-80
Zhao, J-Chun.; Xian, C-Jing.; Yu, J-Ao.; Shi, K.; Hong, L. 2015: Hypertonic Glucose Combined with Negative Pressure Wound Therapy to Prepare Wounds with Pseudomonas aeruginosa Infection for Skin Grafting: A Report of 3 Cases Ostomy/Wound Management 61(6): 28-44
Vetkova, L.G.; Zaĭtsev, L.G.; Khasman, E.L.; Radkevich, S.A.; Moroz, A.F. 1986: Protective effect of a corpuscular polyvalent Pseudomonas aeruginosa vaccine in generalized chronic Pseudomonas aeruginosa infection in mice with cyclophosphamide-induced leukopenia Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 3: 14-18
Güerri-Fernández, R.; Villar-García, J.; Herrera-Fernández, S.; Trenchs-Rodríguez, M.; Fernández-Morato, J.; Moro, L.; Sancho, J.; Grande, L.; Clará, A.; Grau, S.; Horcajada, J.P. 2016: An antimicrobial stewardship program reduces antimicrobial therapy duration and hospital stay in surgical wards Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 29(3): 119-121
Wang, R.; Sun, X.D.; Cai, Q.M. 1989: Study of in vitro antibacterial activity of 19 antimicrobial agents against Pseudomonas aeruginosa Chinese Medical Journal 102(4): 313-318
De Groote, V.N.; Verstraeten, N.; Fauvart, M.; Kint, C.I.; Cornelis, P.; Michiels, J. 2009: Identification of novel persistence genes in Pseudomonas aeruginosa in the combat against emerging antimicrobial resistance Communications in Agricultural and Applied Biological Sciences 74(4): 51-56